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Radiation therapy is an important and effective technique of malignant tumors
treatment [1]. Actual problem of radiotherapy is increasing effectiveness and
reducing side effects of the treatment. Binary technologies of radiation therapy
can be used to improve treatment results. One of the most promising technology
is contrast-enhanced or ”photon-capture” radiotherapy (PCT) [2]. The PCT is
effective at low X-ray energies where the photoelectric effect dominates (up to
about 200 keV). Accordingly, the energy escalation of photon beams leads to a
gradual decrease the effect of the PCT. However, low-energy photons for medium-
and deep-seated tumors are limited due to their low penetrating power. For
irradiation of deep-seated tumours, the megavoltage photon beams from linear
accelerators are widely used, where the Compton effect is maximal and the
photoelectric effect is minimal.
Although the effect of PCT should be low, different studies shows the escalation
of energy in the target volume due to the introduction of dose-enhancing agent
(DEA) at megavolt photon beams [4-6]. Some authors suggest that the observed
effect is caused by the wide energy spectrum of photon beams, which including
the low-energy kilovolt energy range.
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